Lehavim, Israel

Tal Dvir

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tal Dvir: Innovator in Biomaterials

Introduction

Tal Dvir is a prominent inventor based in Lehavim, Israel. He has made significant contributions to the field of biomaterials, holding a total of 5 patents. His work focuses on innovative solutions that have the potential to impact various medical applications.

Latest Patents

Dvir's latest patents include groundbreaking inventions such as "Particles comprising decellularized omentum." This patent discloses a spherical particle made from decellularized omentum, with diameters ranging from 1 nM to 300 μM. The particles can comprise biological cells or biomolecules, and their uses are also explored. Another notable patent is for a "Support medium for 3D printing of biomaterials." This invention presents a transparent, stable, safe, and biodegradable hydrogel-based particulate support medium made of calcium alginate particles. These particles are characterized by a homogeneous average size ranging from 0.1 micrometer to 5 micrometers.

Career Highlights

Tal Dvir is associated with Ramot at Tel Aviv University Ltd., where he continues to advance his research and innovations in biomaterials. His work is recognized for its potential applications in regenerative medicine and tissue engineering.

Collaborations

Dvir collaborates with notable colleagues such as Assaf Shapira and Michal Shevach, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tal Dvir is a leading figure in the field of biomaterials, with a focus on developing innovative solutions that can transform medical practices. His contributions through patents and collaborations highlight his commitment to advancing science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…